Consistently, in vivo studies revealed that xenografts of GBM cells overexpressing MSI1-wt grew significantly bigger tumors than that of Flag-control or MSI1-mutant GBM cells (Figure 1F-G). This evidence concerns the gene MSI1 and glioblastoma.